Biotech startups in Toronto, Ontario
Updated 16 Nov 2026
Not sure about the data?
Download a free 10-row sample first. No account, no payment.
| Company | City | Last round | Amount | Date |
|---|---|---|---|---|
| Specific Biologics | Toronto | Series A | $35.0M | 2026-11-02 |
| Muse | Toronto | Series C | $9.5M | 2022-08-11 |
| BenchSci | Toronto | Series D | $69.6M | 2023-05-25 |
| ODAIA | Toronto | Series B | $25.0M | 2023-05-01 |
| Altis Labs | Toronto | Series A | $25.0M | 2026-09-17 |
| Reunion Neuroscience | Toronto | Series A | $133.0M | 2025-09-16 |
| Future Fertility | Toronto | Series A | $4.1M | 2026-04-23 |
| Radiant Biotherapeutics | Toronto | Series A | $35.0M | 2024-09-11 |
8 rows of the CSV in 5 of its 18 columns.
- The 77 biotech startups in Toronto, Ontario have raised $824.1M in total.
- 7 of them closed their most recent round in the last 12 months, $70.8M combined.
- The largest of those rounds is Specific Biologics' $35.0M Series A, dated November 2026.
- Creative Destruction Lab is an investor in 7 of them, more than any other fund.
- Health care is the most common other sector, with 58 companies (75%).
- 24% were founded in 2020 or later; the median founding year is 2017.
- The most common team size is 1 to 10 employees (59% of companies with a recorded size).
Source: FundingWatcher. Data as of 16 November 2026. "Last 12 months" is the 365 days to that date.
Newest rounds
10 of 77| Company | What they do | Sector | Last round | Amount | Date | Total raised | Investors | Employees | Founded |
|---|---|---|---|---|---|---|---|---|---|
| Specific Biologics | Specific Biologics develops gene editing technologies to treat diseases at the genetic level inside the body. | Biotech | Series A | $35.0M | 2026-11-02 | $36.3M | Creative Destruction Lab, Lumira Ventures, adMare Bio Innovations | 1 to 10 | 2017 |
| Altis Labs | Altis Labs uses AI endpoints to speed clinical trials so new treatments reach patients sooner. | Artificial intelligence | Series A | $25.0M | 2026-09-17 | $31.0M | Creative Destruction Lab, Debiopharm Innovation Fund, Benchstrength | 11 to 50 | 2019 |
| Future Fertility | Future Fertility provides artificial intelligence tools for reproductive medicine. | Artificial intelligence | Series A | $4.1M | 2026-04-23 | $4.1M | M Ventures, Whitecap Venture Partners | 11 to 50 | 2018 |
| Reunion Neuroscience | Reunion Neuroscience develops therapeutic treatments for underserved mental health conditions. | Biotech | Series A | $133.0M | 2025-09-16 | $133.0M | Novo Holdings, Mitsui Global Investment, MPM Capital +2 | 1 to 10 | 2019 |
| Genuine Taste | Genuine Taste produces real animal fat without harming animals to improve alternative meat. | Biotech | Pre-seed | $69K | 2024-12-18 | Antler, Big Idea Ventures, Cycle Momentum +1 | 1 to 10 | 2022 | |
| BenchSci | BenchSci uses machine learning and artificial intelligence to speed up biomedical discovery. | Artificial intelligence | Series D | $69.6M | 2023-05-25 | Creative Destruction Lab, Inovia Capital, Gradient +2 | 251 to 500 | 2015 | |
| ODAIA | ODAIA provides an AI-powered customer data platform for the life sciences industry. | Artificial intelligence | Series B | $25.0M | 2023-05-01 | $43.4M | Alumni Ventures, Bossa Invest, Creative Destruction Lab +2 | 51 to 100 | 2018 |
| Muse | Muse develops brainwave-controlled computing technology that converts brainwaves into digital signals. | Biotech | Series C | $9.5M | 2022-08-11 | $39.9M | Felicis, Export Development Canada, OMERS Ventures +2 | 11 to 50 | 2007 |
| Winterlight Labs | Winterlight Labs builds technology that detects signs of cognitive impairment from speech samples. | Artificial intelligence | Series A | $4.2M | 2019-11-18 | Creative Destruction Lab, Ontario Centres of Excellence, First Star Ventures +2 | 11 to 50 | 2015 | |
| GeneYouIn | GeneYouIn is a Canadian personalized medicine company that developed Pillcheck, a genome analytics and reporting platform. | Biotech | Angel | $150K | 2015-06-20 | $150K | Ontario Centres of Excellence | 11 to 50 | 2012 |
Table 1. Biotech startups in Toronto, Ontario: the 10 newest rounds whose row carries a description, a city, a named fund and an amount. Source: FundingWatcher. Data as of 16 November 2026. Base: 77.
Largest rounds
Last 12 months| # | Company | What they do | Sector | Last round | Amount | Date | Total raised | Investors | Employees | Founded |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Specific Biologics | Specific Biologics develops gene editing technologies to treat diseases at the genetic level inside the body. | Biotech | Series A | $35.0M | 2026-11-02 | $36.3M | Creative Destruction Lab, Lumira Ventures, adMare Bio Innovations | 1 to 10 | 2017 |
| 2 | Altis Labs | Altis Labs uses AI endpoints to speed clinical trials so new treatments reach patients sooner. | Artificial intelligence | Series A | $25.0M | 2026-09-17 | $31.0M | Creative Destruction Lab, Debiopharm Innovation Fund, Benchstrength | 11 to 50 | 2019 |
| 3 | Future Fertility | Future Fertility provides artificial intelligence tools for reproductive medicine. | Artificial intelligence | Series A | $4.1M | 2026-04-23 | $4.1M | M Ventures, Whitecap Venture Partners | 11 to 50 | 2018 |
Table 2. Biotech startups in Toronto, Ontario: the 3 largest rounds of the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Most active investors
By companies backed| # | Investor | Type | Location | Companies | Share | Funded, 12 months | Latest |
|---|---|---|---|---|---|---|---|
| 1 | Creative Destruction Lab | Entrepreneurship program | Toronto, Canada | 7 | 9% | 2 | Specific Biologics, Altis Labs |
| 2 | Export Development Canada | Government investment office | Ottawa, Canada | 3 | 4% | ||
| 3 | Toronto Innovation Acceleration Partners | Venture capital firm | Toronto, Canada | 3 | 4% | ||
| 4 | BDC Capital Corporation | Venture capital firm | Wakefield, United States | 2 | 3% | ||
| 5 | Inovia Capital | Venture capital firm | Montréal, Canada | 2 | 3% | ||
| 6 | Alexandria Venture Investments | Venture capital firm | Pasadena, United States | 2 | 3% | ||
| 7 | FACIT | Venture capital firm | Toronto, Canada | 2 | 3% | ||
| 8 | Ontario Centres of Excellence | Startup accelerator | Toronto, Canada | 2 | 3% | ||
| 9 | adMare Bio Innovations | Startup accelerator | Vancouver, Canada | 1 | 1% | 1 | Specific Biologics |
| 10 | Lumira Ventures | Venture capital firm | Toronto, Canada | 1 | 1% | 1 | Specific Biologics |
| 11 | Felicis | Venture capital firm | Menlo Park, United States | 1 | 1% | ||
| 12 | OMERS Ventures | Venture capital firm | Toronto, Canada | 1 | 1% | ||
| 13 | Alabaster | Venture capital firm | San Francisco, United States | 1 | 1% | ||
| 14 | Northleaf Capital Partners | Private equity firm | Toronto, Canada | 1 | 1% | ||
| 15 | Gradient | Venture capital firm | San Francisco, United States | 1 | 1% |
Table 3. Biotech startups in Toronto, Ontario: the funds recorded as investors in the most companies. Latest: companies they back that raised in the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Sectors
| Sectors | Companies | Share | Total raised |
|---|---|---|---|
| Health care | 58 | 75% | $683.2M |
| Software | 17 | 22% | $379.6M |
| Artificial intelligence | 12 | 16% | $326.4M |
| Hardware | 6 | 8% | $39.9M |
| Fintech | 2 | 3% | $150K |
| Energy | 1 | 1% |
Table 4. Biotech startups in Toronto, Ontario by sector. Source: FundingWatcher. Data as of 16 November 2026.
Funding stage
| Funding stage | Companies | Share | Median last round |
|---|---|---|---|
| Pre-seed | 18 | 23% | $200K |
| Seed | 36 | 47% | $529K |
| Series A | 12 | 16% | $15.3M |
| Series B | 5 | 6% | $18.0M |
| Series C | 4 | 5% | $9.5M |
| Series D+ | 2 | 3% | $114.5M |
Table 5. Biotech startups in Toronto, Ontario by stage of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.
Rounds by month
| Rounds by month | Companies | Share | Raised |
|---|---|---|---|
| November 2026 | 1 | 14% | $35.0M |
| October 2026 | 1 | 14% | $5.8M |
| September 2026 | 2 | 29% | $25.6M |
| June 2026 | 2 | 29% | $225K |
| April 2026 | 1 | 14% | $4.1M |
Table 6. Biotech startups in Toronto, Ontario: most recent round by month, last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Most recent round by year
| Most recent round by year | Companies | Share | Raised |
|---|---|---|---|
| 2026 | 7 | 9% | $70.8M |
| 2025 | 5 | 6% | $154.2M |
| 2024 | 8 | 10% | $60.6M |
| 2023 | 7 | 9% | $113.5M |
| 2022 | 6 | 8% | $13.7M |
| 2021 | 4 | 5% | $180.8M |
Table 7. Biotech startups in Toronto, Ontario by year of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.
Founding year
| Founding year | Companies | Share |
|---|---|---|
| 2023 or later | 7 | 9% |
| 2020 to 2022 | 11 | 15% |
| 2015 to 2019 | 34 | 45% |
| 2010 to 2014 | 13 | 17% |
| Before 2010 | 10 | 13% |
Table 8. Biotech startups in Toronto, Ontario by founding year. Source: FundingWatcher. Data as of 16 November 2026.
Team size
| Team size | Companies | Share |
|---|---|---|
| 1 to 10 | 44 | 59% |
| 11 to 50 | 23 | 31% |
| 51 to 100 | 3 | 4% |
| 101 to 250 | 2 | 3% |
| 251 to 500 | 1 | 1% |
| 501 to 1,000 | 1 | 1% |
| 5,001 to 10,000 | 1 | 1% |
Table 9. Biotech startups in Toronto, Ontario by headcount. Source: FundingWatcher. Data as of 16 November 2026.
Method
- A company is on this list when Biotech is one of its sectors and its headquarters is in Toronto, Ontario. On 16 November 2026 that is 77 companies.
- Stage, round, amount and date are those of the company's most recent funding round. Amounts are in US dollars as the source records them.
- The table prints the 10 newest rounds whose row is complete: a one-sentence description, a city, a named fund and an amount. The CSV carries all 77 rows: 28 have no round amount, 0 no city and 38 no website. The CSV carries domain, website, LinkedIn and the cached description sentence where present.
Sources, fields and exclusions of both files: Method.
Questions
- How many biotech startups in Toronto, Ontario are on the list?
- 77, in the file dated 16 November 2026. 7 of them closed their most recent round in the last 12 months.
- What does the CSV contain?
- One row per company, 18 columns: name, domain, website, linkedin, description, founded, employees, city, region, country, sectors, funding_stage, last_round, last_round_date, last_round_usd, total_raised_usd, rounds, investors.
- How much does the list cost?
- $29 one-time for all 77 rows, no account. Every investor and every startup, two files, cost $99. With founder contacts, up to 2 founders or CEOs per company compiled to order and mailed within 24 hours, $199.
- What arrives after payment?
- At once: the CSV download link, on the page after payment and by mail.
- Can I see rows before buying?
- The 3 rows under the buy button are rows of the CSV with every column. The form below it mails 10 rows.
- How current is the data?
- The file is dated 16 November 2026. The download link serves the current file each time it is opened.
Not sure about the data?
Download a free 10-row sample first. No account, no payment.